Avelolife
2 known investors
Find your way into Avelolife
Sign up to see every warm intro you have to Avelolife
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avelolife team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Avelo develops diagnostic technology aimed at closing the diagnostic gap in respiratory disease, so patients receive timely and accurate information for effective treatment. The company operates in the medical diagnostics field with an emphasis on technology and science.
Investors · 2
Privilège Ventureslisted by Privilège VenturesLugano · $100K – $1M
How we know: Privilège Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Avelolife do?
- Avelo develops diagnostic technology aimed at closing the diagnostic gap in respiratory disease, so patients receive timely and accurate information for effective treatment. The company operates in the medical diagnostics field with an emphasis on technology and science.
- Who are Avelolife's investors?
- Avelolife's investors include OCCIDENT, Privilège Ventures.
